Generali Asset Management SPA SGR acquired a new stake in shares of Xylem Inc. (NYSE:XYL - Free Report) during the 4th quarter, according to its most recent disclosure with the SEC. The fund acquired 10,085 shares of the industrial products company's stock, valued at approximately $1,170,000.
A number of other hedge funds and other institutional investors have also recently made changes to their positions in the company. Rialto Wealth Management LLC bought a new position in Xylem in the fourth quarter worth $31,000. Heck Capital Advisors LLC purchased a new position in shares of Xylem during the 4th quarter valued at about $36,000. Pathway Financial Advisers LLC grew its stake in shares of Xylem by 122.4% during the 4th quarter. Pathway Financial Advisers LLC now owns 318 shares of the industrial products company's stock valued at $37,000 after acquiring an additional 175 shares during the period. SRS Capital Advisors Inc. increased its holdings in Xylem by 69.5% in the 4th quarter. SRS Capital Advisors Inc. now owns 317 shares of the industrial products company's stock worth $37,000 after acquiring an additional 130 shares in the last quarter. Finally, Flagship Wealth Advisors LLC bought a new stake in Xylem during the 4th quarter worth approximately $39,000. Hedge funds and other institutional investors own 87.96% of the company's stock.
Xylem Stock Up 2.1 %
NYSE XYL traded up $2.54 on Tuesday, reaching $123.34. 1,745,429 shares of the stock traded hands, compared to its average volume of 1,226,600. Xylem Inc. has a 12 month low of $113.26 and a 12 month high of $146.08. The company has a fifty day moving average price of $125.34 and a 200-day moving average price of $126.05. The company has a market cap of $29.98 billion, a price-to-earnings ratio of 33.70, a PEG ratio of 2.33 and a beta of 1.08. The company has a debt-to-equity ratio of 0.19, a quick ratio of 1.33 and a current ratio of 1.76.
Xylem (NYSE:XYL - Get Free Report) last announced its earnings results on Tuesday, February 4th. The industrial products company reported $1.18 earnings per share for the quarter, beating the consensus estimate of $1.12 by $0.06. Xylem had a net margin of 10.40% and a return on equity of 9.96%. The company had revenue of $2.30 billion during the quarter, compared to the consensus estimate of $2.18 billion. During the same period last year, the firm earned $0.99 earnings per share. Xylem's revenue was up 8.6% compared to the same quarter last year. As a group, research analysts forecast that Xylem Inc. will post 4.65 EPS for the current fiscal year.
Xylem Increases Dividend
The company also recently announced a quarterly dividend, which was paid on Wednesday, March 19th. Investors of record on Tuesday, February 18th were paid a $0.40 dividend. This is a positive change from Xylem's previous quarterly dividend of $0.36. The ex-dividend date of this dividend was Tuesday, February 18th. This represents a $1.60 dividend on an annualized basis and a yield of 1.30%. Xylem's dividend payout ratio (DPR) is 43.72%.
Wall Street Analysts Forecast Growth
A number of equities analysts have recently weighed in on the company. Robert W. Baird upped their price objective on Xylem from $139.00 to $148.00 and gave the stock an "outperform" rating in a research note on Wednesday, February 5th. Stifel Nicolaus reduced their price target on shares of Xylem from $166.00 to $150.00 and set a "buy" rating on the stock in a research report on Friday, January 24th. Citigroup downgraded shares of Xylem from a "strong-buy" rating to a "hold" rating in a research note on Wednesday, February 5th. Finally, Wolfe Research reiterated a "peer perform" rating on shares of Xylem in a report on Thursday, December 12th. Four research analysts have rated the stock with a hold rating and six have assigned a buy rating to the company. Based on data from MarketBeat.com, the stock presently has an average rating of "Moderate Buy" and a consensus target price of $149.89.
View Our Latest Report on Xylem
About Xylem
(
Free Report)
Xylem Inc, together with its subsidiaries, engages in the design, manufacture, and servicing of engineered products and solutions worldwide. It operates through four segments: Water Infrastructure, Applied Water, Measurement & Control Solutions, and Integrated Solutions and Services. The Water Infrastructure segment offers products, including water, storm water, and wastewater pumps; controls and systems; filtration, disinfection, and biological treatment equipment; and mobile dewatering equipment and rental services under the ADI, Flygt, Godwin, Sanitaire, Magneto, Neptune Benson, Ionpure, Leopold, Wedeco, and Xylem Vue brands.
Recommended Stories

Before you consider Xylem, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Xylem wasn't on the list.
While Xylem currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Almost everyone loves strong dividend-paying stocks, but high yields can signal danger. Discover 20 high-yield dividend stocks paying an unsustainably large percentage of their earnings. Enter your email to get this report and avoid a high-yield dividend trap.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.